Tenet Healthcare reported strong Q4 2023 results, with net income from continuing operations available to common shareholders at $244 million, or $2.30 per diluted share. Adjusted diluted earnings per share from continuing operations was $2.68. Consolidated Adjusted EBITDA increased by 12.8% year-over-year to $1.012 billion.
Net income from continuing operations available to common shareholders was $244 million, or $2.30 per diluted share.
Adjusted diluted earnings per share from continuing operations was $2.68.
Consolidated Adjusted EBITDA of $1.012 billion increased 12.8% over the prior year.
Ambulatory Care Adjusted EBITDA increased 14.0% over the prior year to $464 million.
Tenet provided its outlook for full year 2024 and first quarter 2024, reflecting the sale of South Carolina hospitals and assuming the sale of California hospitals.
Visualization of income flow from segment revenue to net income